PBPanos Bonotis

Panos Bonotis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Panos Bonotis has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Feasibility of Implementing an Electronic Patient-Reported Outcome-Based Digital Health Platform in Pediatric Oncology and Palliative Care: Insights From the MyPal4Kids Multicenter Observational Study

    by Marcel Meyerheim, Lenka Radová, Anna Burns-Gebhart, Marvin Mergen, Pantelis Natsiavas, Panos Bonotis, Christina Karamanidou, Sheila Payne, Julia Downing, Julie Ling, et al.

    Background: Digital health solutions that incorporate electronic patient-reported outcomes (ePROs) hold promise for enhancing communication and patient engagement in pediatric oncology and palliative care. While ePROs are increasingly used in adult populations, their use in children, especially when combined with gamification, remains underexplored. Objective: This MyPal4Kids study aimed to assess the feasibility, acceptability, and user engagement of a digital health platform that integrates ePROs and a serious game, designed for pediatric oncology patients aged 6‐17 years and their caregivers. Methods: A multicenter observational feasibility study was conducted between December 2020 and September 2022 at 3 clinical sites in Germany and the Czech Republic. A total of 83 children and adolescents with cancer, their parent or legal guardian, as well as 10 health care professionals (HCPs) participated. Primary outcomes included platform acceptability and engagement, assessed through recruitment, participation, and attrition rates, adherence, and usability ratings. Secondary outcomes focused on the feasibility of ePRO-based data capture and the perceived impact on HCP workflows and communication. A mixed methods design was used, combining in-app data and surveys with qualitative insights from focus groups. Results: The recruitment rate was 55%, with an attrition rate of 18%. Usability was rated positively, with most users finding the platform intuitive. Sustained engagement declined over time, particularly among older children who found the serious game insufficiently engaging. Adherence varied by age group and HCP involvement. Participants reported increased motivation when symptom reports were acknowledged by HCPs, although the impact on communication was perceived inconsistently. Conclusions: The developed platform shows potential for use in clinical care and research. However, maintaining long-term engagement remains a challenge. Tailoring content to different age groups and strengthening feedback mechanisms from HCPs are critical for improving the user experience. Successful implementation in routine clinical practice will require integration into existing workflows and digital infrastructure, along with ongoing user-driven development.

  • Open Access

    Leveraging Large Language Models in User eXperience (UX) Education when Real Users Are Unavailable

    by Panos Bonotis, Pantelis Angelidis

    In User eXperience (UX) design, engaging with real users is mandatory and essential, especially in healthcare, where understanding patient and professional experiences is crucial. Yet, ethical and logistical barriers often restrict early-stage access. This study presents a pragmatic approach piloted in a UX workshop for undergraduate engineering students at the University of Western Macedonia, where a Large Language Model (ChatGPT) was used to simulate user perspectives when real participants were unavailable. Students created prompts to emulate patient or clinician responses, using the outputs to develop proto-personas, empathy maps, and design ideas. While LLMs cannot replace authentic user research and may reproduce biases, their thoughtful use can enhance UX education by providing an accessible environment for practicing human-centered methods and preparing students for real-world engagement, particularly in healthcare contexts where user access is limited.

  • Open Access

    An Empirical Study of LLMs for Engineering Medical Consent

    by Anastasia Terzi, Panos Bonotis, Christina Zoi, Stamatia Bibi

    The process of obtaining patient informed consent for personal health information management and agreement on treatments has in recent years become a significant burden for healthcare providers, who often struggle to integrate complex consent requirements into existing clinical workflows. The difficulty increases as consent requirements must be continuously updated and maintained to accommodate new templates and regulatory specifications. Recent advances in Large Language Models (LLMs) offer potential on automating the engineering of medical consent. This paper examines the capabilities of popular LLMs (LLaMa, Gemma, DeepSeek and Phi-3) to be used as collaborative tools to help clinicians generate high-quality, compliant, and patient-centric consent forms from natural language inputs. We identified key clinical challenges and evaluated each LLM’s ability to address them through tasks in formalization, comprehensibility, and compliance. Qualitative expert feedback shows that LLMs are effective companions, but a “one-size-fits-all” approach is insufficient. The paper provides useful implications to practitioners that helps them select the appropriate LLM for consent requirements engineering based on the context of the consent requirement.

  • Open Access

    Profile-Aware Consent Management: A Conceptual Framework

    by Anastasia Terzi, Panos Bonotis, Stamatia Bibi

    Managing user consent for personal data remains a persistent challenge across domains such as healthcare, digital services, and research. Static consent mechanisms often fail to reflect user diversity, evolving preferences, and continuous regulatory changes. As part of the CONSENT project, this paper introduces a conceptual framework for Profile-aware Consent Management. The proposed framework leverages user profiling, adaptive form generation, and automated consenting agents to personalize and simplify the consent process while maintaining compliance and transparency. Building upon multi-stakeholder insights gathered from clinicians, citizens, IT managers, and GDPR experts, the study identifies the major pain points in current consent workflows and translates them into technical design requirements. The resulting framework envisions an AI-powered, profile-aware system that dynamically adapts consent presentation and decisions to user needs, supported by a regulatory compliance backbone.

  • Open Access

    Real-World Breast Cancer Mobile Applications for Patients in the Treatment Stage: A Post-Pandemic Scoping Review

    by Panagiota E. Theofilou, Panos Bonotis, Pantelis Angelidis

    Many current digital health tools are not designed to support the complex needs of breast cancer patients undergoing active treatment, even though they frequently endure severe physical and emotional burdens. This gap is particularly important given the growing dependence on mobile health (mHealth) technologies, which have been accelerated by the COVID-19 pandemic. This scoping review aims to identify mobile health applications for breast cancer published since 2020, and to analyze their core functionalities, target populations, and reported limitations. Following PRISMA-ScR guidelines, we included primary studies describing real-world use beyond prototype or pilot phases. Five unique apps were identified, most offering lifestyle coaching, symptom tracking, or psycho-oncological support. This review serves as an initial step toward understanding the current digital landscape, with the goal of informing the development of a new application grounded in real patient needs and designed through participatory methodologies.

  • Open Access

    Enabling Dynamic Consent Through AI and Blockchain: The CONSENT Platform

    by Panos Bonotis, Pantelis Angelidis, Katerina D. Tzimourta, Stamatia Bibi

    The increasing complexity of data ecosystems, especially healthcare, highlights the urgent need for dynamic, user-centric consent management solutions. Traditional static consent models struggle to adapt to evolving privacy regulations, organizational needs, and user expectations. The CONSENT project introduces an innovative Consent Management Platform (CMP) that leverages Artificial Intelligence (AI) and Blockchain technologies to enable secure, transparent, and flexible management of consent in complex data workflows. By combining intelligent consent recommendation mechanisms with tamper-proof decentralized storage, the CONSENT platform aims to empower users with greater control over their data while facilitating organizational compliance with frameworks such as GDPR and CCPA. This paper presents the platforms vision, core technological pillars, and the planned evaluation strategy, including the anticipated implementation in healthcare and digital services, providing insights into how AI and Blockchain can reshape consent management for the healthcare digital age and beyond.


  • Assessing an eHealth Intervention on Quality of Life in Patients With Chronic Lymphocytic Leukemia and Myelodysplastic Syndromes: The MyPal Randomized Controlled Trial

    by Thomas Chatzikonstantinou, Maria Vasilopoulou, Dimitrios Kyrou, Georgios Karakatsoulis, Panagiotis Argyropaidas, Sotiria Besikli-Dimou, Panos Bonotis, Maria Chatzimina, Jana Didi, Christos Dimosthenous, et al.

    PURPOSE: The MyPal study (ClinicalTrials.gov identifier: NCT04370457 ) is a randomized controlled clinical trial assessing an eHealth intervention on the quality of life (QoL) of patients with chronic lymphocytic leukemia (CLL) and myelodysplastic syndromes (MDS). METHODS: Patients who were receiving or had previously received treatment for CLL or MDS were randomly assigned (1:1) to access the MyPal digital health platform versus standard of care. The MyPal platform included a smartphone application used to report QoL status and symptoms via standardized questionnaires or spontaneous reporting. The primary end point was QoL at 12 months, assessed by the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 General Questionnaire and the EuroQol EQ-5D-3L. Secondary end points included physical and emotional functioning, measured by the Integrated Palliative Care Outcome Scale (IPOS) scale, satisfaction with care, measured by the EORTC PATSAT-C33, and overall survival (OS). Additionally, the Edmonton Symptom Assessment System (ESAS), Brief Pain Inventory (BPI), and Emotion Thermometers (ET) QoL questionnaires were assessed only in the intervention group. RESULTS: A total of 171 patients (97 and 74 in the control and intervention arms, respectively) who answered multiple questionnaires were analyzed. The intervention group reported a significant decrease in pain (β 2 = –0.48 [–0.77 to –0.19], P < .001) compared with the control group (β 1 = 0.3 [0.09 to 0.5], P = .01). Communication and pain measured by IPOS reduced equally in both groups (β 2 = 0 [–0.03 to 0.02], P = .82; β 2 = –0.01 [–0.02 to 0], P = .1, respectively). Family involvement significantly increased over time only for the intervention group. The other items of EORTC QLQ-C30, EuroQol EQ-5D-3L, IPOS, and PATSAT-C33 remained unchanged in both groups. The intervention group displayed a significant improvement in all ESAS, BPI, and ET scales. OS was similar in both groups. CONCLUSION: The MyPal intervention improved several QoL aspects and led to a statistically significant decrease in pain compared with the control group.

  • Open Access

    Perceptions and Needs of Stakeholders Regarding MyPal Project’s Electronic Patient-Reported Outcome App: Cross-Sectional Qualitative Focus Group Study

    by Dimitrios Kyrou, Panos Bonotis, Christine Kakalou, Maria Vasilopoulou, Lydia Scarfò, Marcel Meyerheim, Annette Sander, Tomáš Arpáš, Eleni Kazantzaki, Christos Maramis, et al.

    Background: Palliative care is crucial for patients with life-threatening and serious diseases such as cancer, as it addresses their physical, psychosocial, and spiritual needs. Hematological malignancies significantly contribute to global cancer cases, impacting both older adults and children. To meet the increasing demand for palliative care, electronic patient-reported outcome (ePRO) interventions offer valuable insights into patient monitoring and treatment decision-making. The MyPal project developed a digital ePRO solution to improve palliative care by enabling structured symptom reporting and promoting physician-patient communication. Objective: This study aims to explore the perceptions, opinions, and needs of adult and pediatric patients with cancer, caregivers, and health care professionals (HCPs) regarding low-fidelity versions of the MyPal project’s digital solution, which is designed to improve palliative cancer care. Methods: A qualitative, cross-sectional study was conducted using 12 prepilot focus groups (FGs) across 4 European countries (Greece, Italy, Germany, and the Czech Republic) at participating hospitals and research centers. The FGs, held in person, included 61 participants, including 27 (44%) adult patients with chronic lymphocytic leukemia or myelodysplastic syndromes, 19 (31%) children with hematological malignancies or solid tumors and their parents, and 15 (25%) HCPs specializing in oncology and palliative care. A semistructured discussion guide, informed by vignettes and user personas, was used to facilitate discussions. Sessions were audio recorded, transcribed, and analyzed using thematic analysis to identify and extract themes and subthemes from the FG discussions. Results: Three main themes emerged from the FG discussions. The first theme, improved care, showcased the project’s potential to enhance health care through patient-reported measures by improving symptom monitoring, streamlining decision-making, and strengthening physician-patient communication. Patients and caregivers valued the ability to report symptoms remotely, reducing unnecessary hospital visits, while HCPs appreciated having structured patient data to guide treatment. The second theme, digital communication framework, revealed that while participants recognized the benefits of digital tools, they had concerns about data security, privacy, and clarity regarding communication protocols. Questions emerged about how and when HCPs would review and respond to patient-reported data. In the third theme, applicability for use in health care, participants emphasized the importance of the system’s ease of use, particularly for older patients and young children. Concerns were raised about the potential intrusiveness of the system, particularly regarding notification frequency and the impact on daily life. HCPs highlighted workload challenges, suggesting the need for a structured alert system to prioritize urgent cases. Conclusions: Our findings indicate that ePRO-based interventions such as MyPal can improve palliative care by facilitating communication and patient monitoring. However, addressing privacy concerns, optimizing usability for diverse populations, and ensuring seamless integration into clinical workflows are critical for successful adoption. Insights from this study will inform future development and optimization of eHealth interventions in palliative care.


  • Open Access

    PEDRO: A Peer-to-Peer Support Platform for Adverse Drug Reaction Management in Patients with CLL

    by Christos Timamopoulos, Thomas Chatzikonstantinou, Panos Bonotis, Lydia Scarfo, Paolo Ghia, Kostas Stamatopoulos, Anastasia Farmaki, Achilleas Chytas, Alexandros Rekkas, Kalliopi Kastampolidou, et al.

    Chronic Lymphocytic Leukemia (CLL) treatment often leads to adverse drug reactions (ADRs) and drug-drug interactions (DDIs), significantly impacting patients’ quality of life (QoL). To address the challenges in managing ADRs/DDIs, the PEDRO platform was developed to enhance communication between healthcare professionals (HCPs) managing patients with CLL in real-world healthcare settings and experts with significant research profiles in CLL. This paper presents the PEDRO platform built to provide a secure, scalable, and user-friendly solution for peer-to-peer (P2P) support in ADR/DDI management.

  • Open Access

    Enhancing Healthcare Professionals’ Adherence to the MyPal Project Digital Health Intervention Protocol Through Quick Reference Guides

    by Panos Bonotis, Marcel Meyerheim, Christine Kakalou, Lydia Scarfo, Pantelis Natsiavas, Christina Karamanidou

    Randomized Clinical Trials (RCTs) are widely used to evaluate new interventions, including digital health solutions, but their complexity can burden Healthcare Professionals (HCPs). The MyPal project, part of the Horizon 2020 initiative, aimed to implement a digital health intervention for patients with hematological malignancies through two distinct studies – the MyPal-ADULT study for adult patients and the MyPal-CHILD study for pediatric patients. Usability issues identified during rehearsal testing led to the creation of Quick Reference Guides (QRGs) to enhance protocol adherence. Co-designed with the MyPal-CHILD intervention team for consistency and tailored to various clinical sites across four European countries, the QRGs improved adherence, as better scores were observed in the Information Quality category of the Post-Study System Usability Questionnaire, with average scores improving from 3.28 (SD: 1.03) in the rehearsal testing phase with 6 participants to 2.43 (SD: 1.02) in the post-RCT evaluation with 14 participants (p = 0.12; Cohen’s d = 0.83). Similarly, a single-item feature satisfaction questionnaire question on patient registration showed a decrease in mean scores from 3.00 to 2.43 (Cohen’s d = 0.46; p = 0.35).